Literature DB >> 32368045

Nanofibrous Scaffolds Containing Hydroxyapatite and Microfluidic-Prepared Polyamidoamin/BMP-2 Plasmid Dendriplexes for Bone Tissue Engineering Applications.

Mehdi Doosti-Telgerd1, Fatemeh Sadat Mahdavi2, Farzad Moradikhah3, Mohammad Porgham Daryasari1, Rahimeh Bayrami Atashgah1, Banafsheh Dolatyar4, Hamid Akbari Javar5, Ehsan Seyedjafari2, Iman Shabani3, Ehsan Arefian6, Farhood Najafi7, Yaser Abdi8, Mohsen Amini9.   

Abstract

OBJECTIVE: The aim of this study is to fabricate functional scaffolds to gene delivery bone morphogenetic protein-2 (BMP-2) plasmid for bone formation in bone tissue engineering.
METHODS: Dendriplexes (DPs) of generation 4 polyamidoamin (G4-PAMAM)/BMP-2 plasmid were prepared through microfluidic (MF) platform. The physiochemical properties and toxicity of DPs were evaluated by DLS, AFM, FESEM and MTT assay. In order to create a suitable environment for stem cell growth and differentiation, poly-l-lactic acid (PLLA) and poly-l-lactic acid/poly (ethylene oxide) (PLLA/PEO) scaffolds containing hydroxyapatite nanoparticles (HA) and DPs were fabricated by the electrospinning method. The osteogenic potency of the scaffolds on human adipose tissue-derived mesenchymal stem cells (hASCs) was investigated.
RESULTS: The results revealed that tuning the physical properties of DPs by adjusting flow parameters in microfluidic platform can easily improve the cell viability compared to conventional bulk mixing method. Also, the result showed that the presence of HA and DPs in PLLA/PEO scaffold enhanced alkaline phosphatase (ALP) activity and increased the amount of deposited Ca, as well as, related to osteogenesis gen markers.
CONCLUSION: This study indicated that on using the MF platform in preparation of DPs and loading them along with HA in PLLA/PEO scaffold, the osteogenic differentiation of hASCs could be tuned.
© 2020 Doosti-Telgerd et al.

Entities:  

Keywords:  bone tissue engineering; dendriplex; microfluidic; nanofibrous scaffolds

Mesh:

Substances:

Year:  2020        PMID: 32368045      PMCID: PMC7183354          DOI: 10.2147/IJN.S244416

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  34 in total

1.  Combination of 3D tissue engineered scaffold and non-viral gene carrier enhance in vitro DNA expression of mesenchymal stem cells.

Authors:  Hossein Hosseinkhani; Tony Azzam; Hisatoshi Kobayashi; Yosuke Hiraoka; Hitoyata Shimokawa; Abraham J Domb; Yasuhiko Tabata
Journal:  Biomaterials       Date:  2006-04-18       Impact factor: 12.479

2.  A matrix reservoir for improved control of non-viral gene delivery.

Authors:  Carolyn Holladay; Michael Keeney; Udo Greiser; Mary Murphy; Timothy O'Brien; Abhay Pandit
Journal:  J Control Release       Date:  2009-02-20       Impact factor: 9.776

3.  Diffusion of flexible, charged, nanoscopic molecules in solution: Size and pH dependence for PAMAM dendrimer.

Authors:  Prabal K Maiti; Biman Bagchi
Journal:  J Chem Phys       Date:  2009-12-07       Impact factor: 3.488

Review 4.  Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy.

Authors:  Jun Li; Huamin Liang; Jing Liu; Ziyuan Wang
Journal:  Int J Pharm       Date:  2018-05-19       Impact factor: 5.875

5.  RGD peptide-modified dendrimer-entrapped gold nanoparticles enable highly efficient and specific gene delivery to stem cells.

Authors:  Lingdan Kong; Carla S Alves; Wenxiu Hou; Jieru Qiu; Helmuth Möhwald; Helena Tomás; Xiangyang Shi
Journal:  ACS Appl Mater Interfaces       Date:  2015-02-19       Impact factor: 9.229

Review 6.  Bone morphogenetic proteins.

Authors:  Di Chen; Ming Zhao; Gregory R Mundy
Journal:  Growth Factors       Date:  2004-12       Impact factor: 2.511

7.  Improving the Gene Transfection in Human Embryonic Stem Cells: Balancing with Cytotoxicity and Pluripotent Maintenance.

Authors:  Chunhua Luo; Dongyuan Lü; Jun Pan; Mian Long
Journal:  ACS Appl Mater Interfaces       Date:  2016-03-23       Impact factor: 9.229

8.  Enhanced osteogenic differentiation of stem cells via microfluidics synthesized nanoparticles.

Authors:  Mohammad Mahdi Hasani-Sadrabadi; Sana Pour Hajrezaei; Shahriar Hojjati Emami; Ghasem Bahlakeh; Leila Daneshmandi; Erfan Dashtimoghadam; Ehsan Seyedjafari; Karl I Jacob; Lobat Tayebi
Journal:  Nanomedicine       Date:  2015-04-29       Impact factor: 5.307

9.  Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery.

Authors:  Haobo Han; Wenqi Chen; Jiebing Yang; Xiao Liang; Yudi Wang; Quanshun Li; Yan Yang; Kun Li
Journal:  Int J Nanomedicine       Date:  2018-03-06

Review 10.  Polyethylenimine-based nanocarriers in co-delivery of drug and gene: a developing horizon.

Authors:  Abbas Zakeri; Mohammad Amin Jadidi Kouhbanani; Nasrin Beheshtkhoo; Vahid Beigi; Seyyed Mojtaba Mousavi; Seyyed Ali Reza Hashemi; Ayoob Karimi Zade; Ali Mohammad Amani; Amir Savardashtaki; Esmail Mirzaei; Sara Jahandideh; Ahmad Movahedpour
Journal:  Nano Rev Exp       Date:  2018-07-03
View more
  2 in total

1.  (Bio)manufactured Solutions for Treatment of Bone Defects with Emphasis on US-FDA Regulatory Science Perspective.

Authors:  Pejman Ghelich; Mehdi Kazemzadeh-Narbat; Alireza Hassani Najafabadi; Mohamadmahdi Samandari; Adnan Memic; Ali Tamayol
Journal:  Adv Nanobiomed Res       Date:  2022-01-05

2.  In vitro Studies of Polycaprolactone Nanofibrous Scaffolds Containing Novel Gehlenite Nanoparticles.

Authors:  Moloud Amini Baghbadorani; Ashkan Bigham; Mohammad Rafienia; Hossein Salehi
Journal:  J Med Signals Sens       Date:  2021-05-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.